One Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
One Capital Management's IHE Position: Q3 2026 in Review
One Capital Management reduced its iShares US Pharmaceuticals ETF (IHE) stake by 28% in Q3 2026, selling an estimated $380K and leaving 9,499 shares worth $955K. The position accounts for 0.02% of the portfolio, ranked #314.
One Capital Management first reported a position in IHE in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.94M in Q4 2024. 249 funds tracked by Wall St. Rank hold IHE as of Q3 2026.
- One Capital Management held 9,499 shares of iShares US Pharmaceuticals ETF worth $955K as of Q3 2026.
- One Capital Management sold 3,706 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $380K.
- iShares US Pharmaceuticals ETF made up 0.02% of One Capital Management's portfolio in Q3 2026, its #314 holding.
- One Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q3 2023 and has held it in 13 quarters since.
- One Capital Management's iShares US Pharmaceuticals ETF position peaked at $1.94M in Q4 2024.
- 249 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.
Based on One Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.